Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DW-4301 by Daewon Pharmaceutical for Hyperlipidemia: Likelihood of Approval
DW-4301 is under clinical development by Daewon Pharmaceutical and currently in Phase I for Hyperlipidemia. According to GlobalData, Phase I...
DW-4301 by Daewon Pharmaceutical for Dyslipidemia: Likelihood of Approval
DW-4301 is under clinical development by Daewon Pharmaceutical and currently in Phase II for Dyslipidemia. According to GlobalData, Phase II...
DW-4301 by Daewon Pharmaceutical for Hypercholesterolemia: Likelihood of Approval
DW-4301 is under clinical development by Daewon Pharmaceutical and currently in Phase II for Hypercholesterolemia. According to GlobalData, Phase II...
DW-1704 by Daewon Pharmaceutical for Chronic Cerebrospinal Venous Insufficiency (CCSVI): Likelihood of Approval
DW-1704 is under clinical development by Daewon Pharmaceutical and currently in Phase III for Chronic Cerebrospinal Venous Insufficiency (CCSVI). According...
Pelubiprofen SR by Daewon Pharmaceutical for Chronic Low Back Pain (CLBP): Likelihood of Approval
Pelubiprofen SR is under clinical development by Daewon Pharmaceutical and currently in Phase III for Chronic Low Back Pain (CLBP)....